White label ELPA - ClinicalTrials.eu

Study on the Safety and Efficacy of MK-0616 for Adults with High Cholesterol

Not recruiting

3 1 1
Investigated Diseases:
- Hypercholesterolaemia
Investigated Drugs:
- Enlicitide Chloride
+3
Study on Long-term Safety of Weekly Intravenous Alpha-1-Proteinase Inhibitor for Patients with Pulmonary Emphysema Due to Alpha-1-Antitrypsin Deficiency

Not recruiting

3 1 1 1
Investigated Drugs:
- Alpha-1-Proteinase Inhibitor (Human)
Study on the Effectiveness and Safety of Lazertinib and Gefitinib for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
- Gefitinib
- Lazertinib
Study on the Effectiveness and Safety of Tanimilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

Not recruiting

3 1
Investigated Diseases:
- Chronic obstructive pulmonary disease
Investigated Drugs:
- Tanimilast
+6
Study of Ramucirumab and Erlotinib for Patients with EGFR Mutation-Positive Metastatic Non-Small Cell Lung Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:
- Erlotinib
- Ramucirumab
Study on the Effects of Alpha-1-Proteinase Inhibitor for Patients with Pulmonary Emphysema Due to Alpha-1 Antitrypsin Deficiency

Not recruiting

3 1 1
Investigated Diseases:
- Emphysema
Investigated Drugs:
- Alpha-1-Proteinase Inhibitor (Human)
Study on Talazoparib for Maintenance Treatment in Patients with Advanced Malignant Pleural or Peritoneal Mesothelioma After Initial Chemotherapy

Not recruiting

2 1 1 1
Investigated Diseases:
- Pleural mesothelioma malignant
- Peritoneal mesothelioma malignant
Investigated Drugs:
- Talazoparib
Study on the Safety and Effectiveness of Olaparib, Ceralasertib, and AZD1775 for Patients with Metastatic Triple Negative Breast Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Triple negative breast cancer
Investigated Drugs:
- Olaparib
- Ceralasertib
Study on the Safety and Effectiveness of Elafibranor for Adults with Primary Sclerosing Cholangitis

Not recruiting

2 1
Investigated Drugs:
- Elafibranor
Study on the Effectiveness and Safety of CHF6001 DPI with Roflumilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

Not recruiting

3 1
Investigated Diseases:
- Chronic obstructive pulmonary disease
Investigated Drugs:
- Tanimilast
- Roflumilast
+8

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies